Design and optimization of artemether microparticles for bitter taste masking

Acta Pharmaceutica

Volumn 58, Issue 4, 2008, Pages 379-392

  Shah, Punit P ^a   Mashru, Rajashree C ^b   Rane, Yogesh M ^b   Badhan, Atul C ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

32 factorial design; Artemether; Bitterness; Eudragit E 100

Indexed keywords

ARTEMETHER; EUDRAGIT; EUDRAGIT E 100; SODIUM HYDROXIDE; UNCLASSIFIED DRUG;

ARTICLE; BITTER TASTE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DESIGN; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; INFRARED SPECTROSCOPY; MICROENCAPSULATION; MULTIPLE LINEAR REGRESSION ANALYSIS; NORMAL HUMAN; PALATABILITY; PARTICLE SIZE; PH;

EID: 58149145563     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-008-0027-y     Document Type: Article

References (17)

1. T. Yamamoto, T. Nagai, T. Shimura and Y. Yasoshima, Roles of chemical mediators in taste system, Jpn. J. Pharmacol. 76 (1998) 325-348.
2. P. P. Shah, R. C. Mashru, A. R. Thakkar and A. C. Badhan, Effect of chitosan crosslinking on bitterness evaluation of artemether using response surface methodology, J. Pharm. Pharmacol. 60 (2008) 421-427; DOI: 10.1211/jpp.60.4.0003.
3. P. P. Shah and R. C. Mashru, Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique, AAPS PharmSciTech 9 (2008) 494-500; DOI: 10.1208/s12249-008-9066-4.
4. H. Sohi, Y. Sultana and R. K. Khar, Taste masking technologies in oral pharmaceuticals: recent developments and approaches, Drug. Dev. Ind. Pharm. 30 (2004) 429-448; DOI: 10.1081/DDC-120037477.
5. E. Esposito, R. Rancarati, R. Cortesi, F. Cervellati and C. Nastruzzi, Production of Eudragit microparticles by spray-drying technique: Influence of experimental parameters on morphological and dimensional characteristics, Pharm. Dev. Tech. 5 (2000) 267-278; DOI: 10.1081/PDT-100100541.
6. Y. Hashimoto, M. Tanaka, H. Kishimoto, H. Shiozawa, K. Hasegawa, K. Matsuyama and T. Uchida, Preparation, characterization and taste masking properties of polyvinylacetal diethylamino acetate microsphere containing trimebutine, J. Pharm. Pharmacol. 54 (2002) 1323-1328.
7. T. Ishikawa, Y. Watanabe, N. Utoguchi and M. Matsumoto, Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter taste-masked granules by direct compression method, Chem. Pharm. Bull. 47 (1999) 1451-1454.
8. Y. Gao, F. Cui, Y. Guan, L. Yang, Y. Wang and L. Zhang, Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking, Int. J. Pharm. 318 (2006) 62-69; DOI: 10.1016/j.ijpharm.2006.03.018.
9. Y. M. Rane, R. C. Mashru, M. G. Sankalia and J. M. Sankalia, Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersion studied using response surface methodology, AAPS PharmSciTech 8 (2007) article 27; DOI: 10.1208/pt0802027.
10. P. P. Shah, R. C. Mashru, Y. M. Rane and A. R. Thakkar, Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking, AAPS PharmSciTech 9 (2008) 377-389; DOI: 10.1208/s12249-008-9052-x.
11. United States Pharmacopoeia XXIV, National Formulary XIX, USP Pharmacopoeilal Convention, Rockville 2000, pp. 1941-1943.
12. Y. M. Rane, R. C. Mashru, M. G. Sankalia, V. B. Sutariya and P. P. Shah, Investigation on factors affecting chitosan for dissolution enhancement of oxcarbazapine by spray dried microcrystal formulation with an experimental design approach, Drug. Dev. Ind. Pharm. 33 (2007) 1008-1023; DOI: 10.1080/03639040601179749.
13. 2 factorial design, Drug. Dev. Ind. Pharm. 28 (2002) 77-87; DOI: 10.1081/DDC-120001488.
14. T. J. Shah, A. F. Amin, J. R. Parikh and R. H. Parikh, Process optimization and characterization of poloxamer solid dispersion of a poorly water soluble drug, AAPS PharmSciTech 8 (2007) article 29; DOI: 10.1208/pt0802029.
15. S. Bolton and S. Charles, Pharmaceutical Statistics, Marcel Dekker, New York 2004.
16. P. M. Satturwar, P. M. Mandaogade and A. K. Dorle, A novel method for preparation of Eudragit RL microcapsules, J. Microencapsul. 19 (2002) 407-413; DOI: 10.1080/02652040210140454.
17. H. Valizadeh, A. Nokhodchi, N. Qarakhani, P. Zakeri-Milani, S. Azarmi, D. Hassanzadeh and R. Lobenberg, Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin and Eudragit E100, Drug. Dev. Ind. Pharm. 30 (2004) 303-317; DOI: 10.1081/DDC-120030426.